1,359
Views
0
CrossRef citations to date
0
Altmetric
Clinical Study

Association between serum uric acid levels and clinical outcomes in patients with acute kidney injury

, , , , , , , & show all
Article: 2169617 | Received 25 Oct 2022, Accepted 13 Jan 2023, Published online: 19 Apr 2023

References

  • Al-Jaghbeer M, Dealmeida D, Bilderback A, et al. Clinical decision support for in-hospital AKI. J Am Soc Nephrol. 2018;29(2):654–660.
  • Susantitaphong P, Cruz DN, Cerda J, Acute Kidney Injury Advisory Group of the American Society of Nephrology, et al. World incidence of AKI: a meta-analysis. Clin J Am Soc Nephrol. 2013;8(9):1482–1493.
  • Case J, Khan S, Khalid R, et al. Epidemiology of acute kidney injury in the intensive care unit. Crit Care Res Pract. 2013;2013:479730.
  • Wang H, Muntner P, Chertow G, et al. Acute kidney injury and mortality in hospitalized patients. Am J Nephrol. 2012;35(4):349–355.
  • Mehta R, Pascual M, Soroko S, Program to Improve Care in Acute Renal Disease, et al. Spectrum of acute renal failure in the intensive care unit: the PICARD experience. Kidney Int. 2004;66(4):1613–1621.
  • Barrantes F, Tian J, Vazquez R, et al. Acute kidney injury criteria predict outcomes of critically ill patients. Crit Care Med. 2008;36(5):1397–1403.
  • Chertow G, Burdick E, Honour M, et al. Acute kidney injury, mortality, length of stay, and costs in hospitalized patients. J Am Soc Nephrol. 2005;16(11):3365–3370.
  • Susic D, Frohlich E. Hyperuricemia: a biomarker of renal hemodynamic impairment. Cardiorenal Med. 2015;5(3):175–182.
  • Suliman M, Johnson R, García-López E, et al. J-shaped mortality relationship for uric acid in CKD. Am J Kidney Dis. 2006;48(5):761–771.
  • Feig DI, Kang DH, Johnson RJ. Uric acid and cardiovascular risk. N Engl J Med. 2008;359(17):1811–1821.
  • Nakagawa T, Kang DH, Feig D, et al. Unearthing uric acid: an ancient factor with recently found significance in renal and cardiovascular disease. Kidney Int. 2006;69(10):1722–1725.
  • Kim SY, Guevara JP, Kim KM, et al. Hyperuricemia and risk of stroke: a systematic review and meta-analysis. Arthritis Rheum. 2009;61(7):885–892.
  • Fang J, Alderman MH. Serum uric acid and cardiovascular mortality the NHANES I epidemiologic follow-up study, 1971–1992. National health and nutrition examination survey. Jama. 2000;283(18):2404–2410.
  • Srivastava A, Kaze AD, McMullan CJ, et al. Uric Acid and the risks of kidney failure and death in individuals with CKD. Am J Kidney Dis. 2018;71(3):362–370.
  • Liu W, Hung C, Chen S, et al. Association of hyperuricemia with renal outcomes, cardiovascular disease, and mortality. Clin J Am Soc Nephrol. 2012;7(4):541–548.
  • Latif W, Karaboyas A, Tong L, et al. Uric acid levels and all-cause and cardiovascular mortality in the hemodialysis population. Clin J Am Soc Nephrol. 2011;6(10):2470–2477.
  • Lee SM, Lee AL, Winters TJ, et al. Low serum uric acid level is a risk factor for death in incident hemodialysis patients. Am J Nephrol. 2009;29(2):79–85.
  • Beberashvili I, Erlich A, Azar A, et al. Longitudinal Study of serum uric acid, nutritional status, and mortality in maintenance hemodialysis patients. Clin J Am Soc Nephrol. 2016;11(6):1015–1023.
  • Park C, Obi Y, Streja E, et al. Serum uric acid, protein intake and mortality in hemodialysis patients. Nephrol Dial Transplant. 2017;32(10):1750–1757.
  • Beberashvili I, Sinuani I, Azar A, et al. Serum uric acid as a clinically useful nutritional marker and predictor of outcome in maintenance hemodialysis patients. Nutrition. 2015;31(1):138–147.
  • Kim C, Jin D, Yun Y, et al. Relationship between serum uric acid and mortality among hemodialysis patients: retrospective analysis of korean end-stage renal disease registry data. Kidney Res Clin Pract. 2017;36(4):368–376.
  • Kang M, Chin H, Joo K, et al. Hyperuricemia is associated with acute kidney injury and all-cause mortality in hospitalized patients. Nephrology (Carlton). 2019;24(7):718–724.
  • Özgür Y, Akın S, Yılmaz NG, et al. Uric acid albumin ratio as a predictive marker of short-term mortality in patients with acute kidney injury. Clin Exp Emerg Med. 2021;8(2):82–88.
  • Andrassy KM. Comments on 'KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney Int. 2013;84(3):622–623.
  • Angeli P, Ginès P, Wong F, et al. Diagnosis and management of acute kidney injury in patients with cirrhosis: revised consensus recommendations of the international club of ascites. J Hepatol. 2015;62(4):968–974.
  • Hoste E, Clermont G, Kersten A, et al. RIFLE criteria for acute kidney injury are associated with hospital mortality in critically ill patients: a cohort analysis. Crit Care. 2006;10(3):R73. London, England)
  • Doi K, Rabb H. Impact of acute kidney injury on distant organ function: recent findings and potential therapeutic targets. Kidney Int. 2016;89(3):555–564.
  • Deswal A, Petersen NJ, Feldman AM, et al. Cytokines and cytokine receptors in advanced heart failure: an analysis of the cytokine database from the vesnarinone trial (VEST). Circulation. 2001;103(16):2055–2059.
  • Pierce C, Larson D. Inflammatory cytokine inhibition of erythropoiesis in patients implanted with a mechanical circulatory assist device. Perfusion. 2005;20(2):83–90.
  • Grander W, Dünser M, Stollenwerk B, et al. C-reactive protein levels and post-ICU mortality in nonsurgical intensive care patients. Chest. 2010;138(4):856–862.
  • Hahn K, Kanbay M, Lanaspa M, et al. Serum uric acid and acute kidney injury: a mini review. Journal of Advanced Research. 2017;8(5):529–536.
  • Murea M, Tucker BM. The physiology of uric acid and the impact of end-stage kidney disease and dialysis. Semin Dial. 2019;32(1):47–57.
  • Wright PA. Nitrogen excretion: three end products, many physiological roles. J Exp Biol. 1995;198(Pt 2):273–281.
  • Becker BF. Towards the physiological function of uric acid. Free Radic Biol Med. 1993;14(6):615–631.
  • Davies KJ, Sevanian A, Muakkassah-Kelly SF, et al. Uric acid-iron ion complexes. A new aspect of the antioxidant functions of uric acid. Biochem J. 1986;235(3):747–754.
  • Li L, Yang C, Zhao Y, et al. Is hyperuricemia an independent risk factor for new-onset chronic kidney disease?: a systematic review and meta-analysis based on observational cohort studies. BMC Nephrol. 2014;15:122.
  • Ali T, Khan I, Simpson W, et al. Incidence and outcomes in acute kidney injury: a comprehensive population-based study. J Am Soc Nephrol. 2007;18(4):1292–1298.
  • Wu V, Huang T, Lai C, et al. Acute-on-chronic kidney injury at hospital discharge is associated with long-term dialysis and mortality. Kidney Int. 2011;80(11):1222–1230.
  • Kanbay M, Huddam B, Azak A, et al. A randomized study of allopurinol on endothelial function and estimated glomular filtration rate in asymptomatic hyperuricemic subjects with normal renal function. Clin J Am Soc Nephrol. 2011;6(8):1887–1894.
  • Roncal CA, Mu W, Croker B, et al. Effect of elevated serum uric acid on cisplatin-induced acute renal failure. Am J Physiol Renal Physiol. 2007;292(1):F116–122.
  • Ejaz A, Dass B, Lingegowda V, et al. Effect of uric acid lowering therapy on the prevention of acute kidney injury in cardiovascular surgery. Int Urol Nephrol. 2013;45(2):449–458.
  • Galardy PJ, Hochberg J, Perkins SL, et al. Rasburicase in the prevention of laboratory/clinical tumour lysis syndrome in children with advanced mature B-NHL: a children’s oncology group report. Br J Haematol. 2013;163(3):365–372.